Magazine Article | December 24, 2014

Overlooking GMP Biopharm Education/Training Can Cost You – Big Time

Source: Life Science Leader

Today, GMP-compliant manufacturing of biopharmaceutical drugs and vaccines is still only partially automated and not at the level of other manufacturing industries. Critical process steps such as sampling, sterile connection, or column packing are carried out manually by operators, which can negatively impact process reproducibility, product quality, and — in the worst case — even patient safety.